Evaluation of VP-16-213, cyclophosphamide, doxorubicin, and cisplatin (V-CAP) in advanced large cell lung cancer

R. T. Eagan, S. Frytak, W. C. Nichols, J. N. Ingle, E. T. Creagan, L. K. Kvols, D. T. Coles

Research output: Contribution to journalArticle

9 Scopus citations
Original languageEnglish (US)
Pages (from-to)715-717
Number of pages3
JournalCancer Treatment Reports
Volume65
Issue number7-8
StatePublished - Oct 26 1981

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Eagan, R. T., Frytak, S., Nichols, W. C., Ingle, J. N., Creagan, E. T., Kvols, L. K., & Coles, D. T. (1981). Evaluation of VP-16-213, cyclophosphamide, doxorubicin, and cisplatin (V-CAP) in advanced large cell lung cancer. Cancer Treatment Reports, 65(7-8), 715-717.